| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |